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Abstract We have investigated the adenylyl cyclase (AC) 
activity and gene expression in retinoic acid (RA)-primed murine 
P19 teratocarcinoma cells, which recapitulate in vitro the first 
stages of neuroectodermal formation. Here we show that the P19 
stem cells possess a basal Ca2+/CaM-stimulated AC activity, 
which increases about 10-fold after RA induction. The rise of AC 
activity is associated with a stage-specific up-regulation of AC2, 
AC5 and AC8 mRNAs and a down-regulation of AC3 mRNA. 
P19 cells provide a powerful model to investigate the role and 
specific regulation of AC isoforms during neuronal differentia-
tion. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The vitamin A derivative retinoic acid (RA) is an important 
natural morphogen in vertebrates, involved in specifying the 
anteroposterior axis and the central nervous system [1,2]. Se-
vere congenital vitamin A deficiencies result in a spectrum of 
malformations including defects of eye, lung, cardiovascular 
and urogenital systems [3]. Endogenous RA applied to em-
bryos during an early stage of development causes severe 
malformations, particularly within the hindbrain and bran-
chial region of the head [2]. 
It is well established that retinoids exert their biological 
activity via three types of proteins: the cellular RA-binding 
proteins CRABP-I and II, the cellular retinol-binding proteins 
CRBP-I and II, and the nuclear RA receptors (RARs) or 
retinoid X receptors (RXRs). The latter are ligand-inducible 
transcriptional frans-regulators modulating the transcription 
of target genes via rii-acting DNA response elements 
(RAREs) [4,5]. Among the RA-responsive genes, some encode 
transcription factors or putative transcription factors such as 
OCT3 or HOX genes, which are known to be implicated in 
the patterning of the central nervous system [6]. 
Neuronal differentiation in vivo as well as in vitro requires 
elevation of the intracellular cyclic AMP (cAMP) concentra-
tion and is mediated by the cAMP/protein kinase A (PKA) 
cascade [7,8]. The intracellular level of cAMP is controlled 
mainly by the activity of adenylyl cyclases (AC). ACs form 
an enzyme superfamily that consists of at least nine isoforms 
(AC 1-9) with distinct basal activity, regulation, tissue distri-
bution and specific regulation during postnatal development 
[9,10]. These cyclases can be distributed in various subfamilies 
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according to their sensitivity to calcium: AC1, AC3 and AC8 
are activated by the calcium/calmodulin (CaM) complex; 
AC2, AC4 and AC7 are activated by ßy subunits and PKC 
phosphorylation; AC5 and AC6 are inhibited by low concen-
trations of calcium, and AC9 is insensitive to either calcium or 
ßy subunit. The complexity and diversity of AC regulation 
suggest that the AC isoforms could play a major role in con-
trolling the level of cAMP, a critical determinant of embry-
onic development. 
However, no data are currently available concerning the 
isoform-specific regulation of AC during embryonic develop-
ment. The aim of this study was to characterize the isoform-
specific regulation of AC during neuronal induction, using as 
a model murine embryonic carcinoma P19 cells since they can 
mimic in vitro cellular differentiation along the neuroectoder-
mal pathway, when aggregated and exposed to 1 uM RA 
[11,12]. 
Here we report that RA induction of PI9 cells leads to a 
marked increase of Ca2+/CaM-stimulated AC activity, accom-
panied by a specific up-regulation of AC2, AC5 and AC8. 
2. Materials and methods 
2.1. Materials 
ATP, GTP, cAMP, phosphocreatine, creatine phosphokinase, iV-(6-
aminohexyl)-5-chloro-l-naphthalenesulfonamide-HCl (W7) and for-
skolin (FSK) were purchased from Sigma Chemical. [a-32P]ATP (30 
Ci/mmol), [8-3H]cyclic AMP (30 Ci/mmol), [a-32P]dCTP (3000 Ci/ 
mmol), [y-32P]ATP (5000 Ci/mmol) and UTP (800 Ci/mmol) were 
obtained from Amersham. All other chemicals were of the highest 
purity commercially available. 
2.2. Cell culture and growth conditions 
Embryonal carcinoma P19 cells were kindly provided by Dr. M. 
Nemer (University of Montreal). The cells were cultured as mono-
layers in DMEM supplemented with 5% fetal calf serum at 37°C 
and in 5% C02. Neuronal differentiation was achieved as described 
elsewhere [13]. Differentiation was induced by plating cells into bac-
teriological grade Petri dishes at 105 cells/ml in DMEM supplemented 
with 10% fetal calf serum and 1 uM RA. Under these conditions, cells 
aggregate. After 4 days the aggregates were plated into tissue grade 
Petri dishes, whereupon morphological differentiation occurred. Neu-
rons were identified as rounded cells with elongated axonal or den-
dritic processes, glial and other non-neuronal cells were seen as flat 
fibroblast shaped cells. Morphologically identifiable neurons and glial 
cells were observed in the cultures starting from day 5 after RA in-
duction. Days of differentiation were numbered consecutively after the 
first day of RA treatment. 
2.3. Assay of adenylyl cyclase activity 
AC activity of purified PI9 plasma membranes was measured as 
described previously [14] with some modifications. To obtain purified 
membranes, the cells were washed twice with ice-cold PBS, homogen-
ized in 10 volumes of ice-cold lysis buffer (10 mM Tris-HCl (pH 7.6), 
0.1 mM EGTA, 5 mM 2-mercaptoethanol and 0.5 mM PMSF (phen-
ylmethylsulfonyl fluoride)) and centrifuged at 500 X g for 5 min at 
4°C. The supernatant was centrifuged at 17000Xg for 30 min at 
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4°C and the pellet washed in the same buffer three times. For analysis 
of the calcium effect on AC activity, the membranes were washed 
twice with 1 mM EGTA. The final pellet corresponding to the mem-
brane fraction was resuspended in the lysis buffer to a final protein 
concentration of 2-4 mg/ml and stored at — 80°C. 
The standard AC assay contained 70 mM Tris-HCl (pH 7.6), 5 mM 
MgCl2, 1 mM ATP (disodium salt), 1X 10
6 cpm/assay [cc-32P]ATP 
(tetra(triethylammonium) salt) (Amersham), 1 mM cAMP containing 
[8-3H]cAMP (10-15 X 103 cpm/assay), 5 mM phosphocreatine (disodi-
um salt), 60 U/ml creatine phosphokinase and 20-40 |ig of membrane 
proteins in a final volume of 60 ul. The reactions were initiated by 
addition of the membranes, conducted for 10 min at 35°C and termi-
nated by addition of 200 (il of 0.5 M HC1, followed by boiling for 
7 min, and neutralized by 200 JJ.1 of 10 mM imidazole (pH 7.6). cAMP 
formed during the incubation was separated by Aluminia column and 
corrected for recovery of added [3H]cAMP [15]. Data points are pre-
sented as mean activities ± S.E.M. of triplicate determinations. 
Free concentrations of Ca2+ were calculated as described [16]. 
2.4. Probes 
Probes specific for each of the AC subtypes were chosen from 
regions where the sequences are the most divergent. The 700 bp Hin-
dlll-itoraHI fragment used for the AC1 probe was isolated from the 
bovine AC1 sequence [17]. Probes specific for rat AC2, AC3, and 
mouse AC8 were obtained by reverse-transcription PCR (RT-PCR) 
using mRNA extracted from brain and specific following oligonucleo-
tides: 5'-GGGAAGATTAGTACCACGGT-3' and 5'-AGGAGAA-
GCCAAGGATGGACG-3' for 345 bp rat AC2 probe [18]; 5'-AT-
GAGCACGAACTGAACCAGCT-3' and 5'-GTCCCATGTAGTAC 
TGGAGACAGCTC-3' for the 455 bp rat AC3 [19,20]; and 5'-
CAGTCTGGGCCTGAGGAAATT-3' and 5'-AAGTCAGGTTCT-
TCAAGGGTA-3' for the 477 bp mouse AC8 probe. The amplified 
fragments were subcloned in the Smal site of pGEM3 (Promega). A 
722 bp fragment derived from the mouse AC7 cDNA [21] was in-
serted in the TA cloning site of pCRII. Probes specific for AC4, AC5, 
AC6 and AC9 were obtained as described [22]. A mouse ß-actin frag-
ment (Smal-Kpnl; 822 bp) was used as a control in all Northern blots 
[23]. A chicken calmodulin cDNA fragment, cross-hybridizing with 
CaMI, II and III, was used as a probe for CaM [24]. 
The probes were labeled with [ot-32P]dCTP by the Megaprime label-
ing system (Amersham) according to the manufacturer's instructions. 
2.5. RNA preparations and Northern blotting 
Total RNA was extracted by the guanidinium thiocyanate/phenol 
extraction method [25]. Poly(A)+ RNA was selected by binding to 
oligo(dT) cellulose. For Northern blots, 10 ug o f Pofy(A)+ RNAs 
or 30 ug of total RNAs were electrophoresed on 1% agarose gel 
containing 2.2 M formaldehyde and transferred overnight onto Hy-
bond N + membrane (Amersham) by capillary blotting. Hybridization 
with specific cDNA probes was carried out using Rapid-hyb buffer 
(Amersham) according to the manufacturer's instructions. Hybridiza-
tion with the ß-actin probe was used as an internal control to estimate 
the amount of total or poly(A)+ RNA loaded in each well and the 
efficiency of the transfer. The membranes were washed for 15 min in 
2XSSC, 0.1% SDS at room temperature, twice 0.2XSSC, 0.1% SDS 
at 65°C and exposed to Kodak XAR film at -80°C. Instant Imager 
analysis of the Northern blots was used for quantification of the 
signal intensity. 
3. Results 
3.1. Adenylyl cyclase activity increases with time in RA-primed 
P19 cells. Ca2+ sensitivity 
The evolution of AC activity in P19 plasma membranes as a 
function of time after RA induction is depicted in Fig. 1. 
After a 3 day lag period, basal AC activity increased 10-fold 
on day 7. The evolution of FSK-stimulated AC activity as a 
function of time was quite similar with a 5-fold increase at 
day 7. 
AC activity was studied as a function of Ca2+ concentration 
in membranes from undifferentiated (UD) cells (Fig. 2A) and 
from RA-induced cells (day 7) (Fig. 2B). In the presence of 
1 uM CaM added, the basal AC activities in both cases were 
stimulated by the Ca2+/CaM complex by 5- and 3-fold in UD 
and RA-induced cells respectively (Fig. 2). Without CaM 
added, the basal AC activity in membranes from UD cells 
did not change markedly with the various concentrations of 
Ca2+ (Fig. 2A). The small increase in AC activity of differ-
entiated cells observed in the presence of Ca2+ alone, without 
CaM added (Fig. 2B), is probably due to the large amount of 
endogenous CaM already present in neuronal cell membranes. 
Addition of W7, a drug which inhibits the binding of Ca2+ to 
CaM, totally abolished this stimulation of AC activity, con-
firming the specificity of the effect observed (Fig. 2B). 
3.2. Determination of AC isoform mRNAs expressed in UD 
and RA-primed PI9 cells 
To determine the expression of AC genes in the course of 
RA-induced differentiation, Northern blot experiments were 
conducted with mRNAs isolated from UD and RA-induced 
cells (day 3 and day 7). Following hybridization of Northern 
blots with specific cDNA probes, undifferentiated P19 cells 
expressed mainly AC6 and AC3 mRNAs (Fig. 3A). mRNAs 
for AC2, AC5, AC7, AC8 and AC9 were detected in UD cells 
at very low levels, while mRNAs for AC1 and AC4 were 
undetectable (Fig. 3A and data not shown). 
While the levels of mRNAs of AC7 and AC9 were stable 
during the course of differentiation, dramatic changes in the 
expression of AC2, AC3, AC5, AC6 and AC8 were observed 
(Fig. 3). AC2 mRNA increased 20-fold at day 3 and up to 30-
fold at day 7. AC3 mRNA diminished markedly at day 3 and 
was even further reduced by day 7. AC6 mRNAs increased at 
day 3 (2.8-fold) and decreased in neuronally differentiated 
cells. AC5 and AC8 mRNAs were markedly increased by 8-
and 10-fold respectively at day 7. 
3.3. Isoform-specific increase of calmodulin mRNA in 
RA-primed PI9 cells 
The developmental increase of Ca2+/CaM-stimulated AC 
activity in differentiated neuronal cells was accompanied by 
an isoform-specific increase of CaM itself (Fig. 4). Different 
Time (Days) 
Fig. 1. AC activity in membranes prepared from P19 cells during 
the course of neuronal differentiation. P19 teratocarcinoma cells 
were induced to differentiate along the neuroectodermal pathway by 
aggregating in the presence of 1 uM RA. Each day AC activity was 
assayed on an aliquot in the absence (basal) or in the presence of 
100 uM forskolin (FSK). Each point represents the mean ± S.E.M. 
(bars) value of triplicate determinations from a representative ex-
periment. 
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Fig. 2. Effect of Ca2+ and calmodulin on AC activity in membranes from UD (A) and differentiated (B) P19 cells. AC activities were assayed 
in the absence (basal) or in the presence of 1 uM calmodulin (CaM). W7, a specific inhibitor of CaM, was added to some assays to abohsh 
the effect of endogenous CaM. Free concentrations of Ca2+ were adjusted using EGTA/CaCl2 buffers. Each point represents the mean ± S.E.M. 
(bars) value of triplicate determinations from a representative experiment. 
CaM mRNAs have been described [26], originating from a 
tree of different genes. Four species of calmodulin mRNAs 
(4.0 and 1.7 kbp for CaM-I, 1.4 kbp for CaM-II and 2.3 kbp 
for CaM-III) were detectable in P19 UD cells and an isoform-
specific regulation of CaM expression occurred in the course 
of neuronal differentiation. CaM-I (1.7 kbp) and CaM-II 
(1.4 kbp) increased about 2-fold in aggregates on day 3, and 
subsequently remained so during the course of differentia-
tion (Fig. 4). The two other CaM isoform mRNAs did not 
change. 
4. Discussion 
4.1. The basal Ca2+1CaM-stimulated AC activity in P19 cells 
increases upon RA-induced neuroectodermal differentiation 
In this paper, we show for the first time that the P19 stem 
cell line possesses a basal AC activity stimulated by the Ca2+/ 
CaM complex. This Ca2+/CaM-stimulated activity, very low 
in UD cells, increases about 10-fold after RA induction. This 
result indicates that, at an early stage of development when 
ACs are apparently still loosely coupled to G-proteins, and 
when the repertoire of receptors, hormones and paracrine 
factors is still very limited, calcium might represent a key 
factor of regulation. Specific spontaneous Ca2+ transients, 
observed in developing neurons, have been reported to be 
sufficient and necessary to drive normal differentiation and 
are required for the normal expression of y-aminobutyric 
acid or for the regulation of neurite extension [27,28]. More-
over, it has recently been shown that the calcium binding 
protein calreticulin can interfere with the RAR and RXR 
signaling pathways to disrupt retinoid-induced differentiation 
[29]. 
The specific AC isoform(s) responsible for this calcium sen-
sitivity has not yet been identified. AC3 and AC8 are both 
expressed in UD cells at a low level, while AC1 mRNA was 
never detected. AC8 can be directly stimulated by Ca2+/CaM 
[30,31], whereas AC3 is stimulated by the Ca2+/CaM complex 
only when the enzyme is previously activated by other effec-
tors, such as GppNHp or forskolin [32]. For this reason, AC3 
is unlikely to be responsible for the calcium-stimulated activ-
ity. Furthermore, its mRNA completely disappeared in neuro-
nally differentiated P19 cells. Thus, our data, together with the 
known biochemical properties of the different AC isoforms 
[30-33], suggest that AC8 is responsible for the Ca2+/CaM-
stimulated activity both in UD and RA-induced cells. How-
ever, a new isoform cannot be completely excluded. 
The importance of the calcium signaling pathway in neuro-
nal differentiation is supported by the isoform-specific induc-
tion of CaM gene expression after RA treatment. Three differ-
ent calmodulin genes and at least five transcripts encode an 
identical, highly conserved protein [26], and exhibit a tissue-
specific developmental pattern of expression related to calm-
odulin synthesis [34]. Our data fit well with this observation. 
4.2. Specific regulation of AC2, AC3, AC5 in course of 
RA-induced differentiation 
RA induction of PI 9 cells leads to specific up-regulation of 
AC2 mRNA and to down-regulation of AC3 mRNA. The 
AC6 mRNA increase could be considered non-specific, be-
cause it was also observed in cells aggregated without any 
inductor of differentiation (data not shown). One might hy-
pothesize that the promoters of AC2 and AC3 contain 
RAREs or responsive elements for the RA-activated tran-
scription factors, such as HOX, OCT or JUN. 
It is possible that a part of the total AC activity increase is 
due to AC2 expression during the course of RA-induced dif-
ferentiation. This isoform has a high basal activity and is 
stimulated by all known signaling molecules, such as Gas, 
ßy as well as PKC [35-38]. The cells in which AC2 is the 
predominant isoform may then be able to integrate several 
positive signals received through multiple channels, and rap-
idly influence the intracellular cAMP level. Finally, the in-
crease in AC5 mRNA that we observed is not surprising since, 
although it is a good marker of adult myocardium [39], it is 
enriched in the striatum where it shows a specific pattern of 
development [40]. 
Thus, a specific set of ACs is expressed in UD P19 cells and 
is specifically modified upon RA-induced differentiation, thus 
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Fig. 3. Determination of AC isoforms expressed in UD and RA-induced P19. A: Northern blot analysis of poly(A)+ RNA extracted from UD 
or RA-induced (day 3 and day 7) PI9 cells. 10 |ig of poly(A)+ RNA obtained from different cell types or 2 |ig of poly(A)+ RNA from mouse 
brain was loaded in each line. Filters were hybridized to 32P-labeled cDNA probes for the indicated AC isoforms, and afterwards for ß-actin. 
Autoradiograms were obtained after exposure for 1 h (ß-actin), 6 h (AC6) or 3 days (others ACs). B : Quantification of the changes in mRNA 
for the different AC isoforms during the course of RA-induced differentiation of P19 cells. Filters were scanned and analyzed using the Instant 
Imager system. The amount of mRNA for each AC was corrected according to the quantity of mRNA for ß-actin and normalized to an arbi-
trary value of 1 for the UD sample. 
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Fig. 4. Type-specific induction of calmodulin mRNA during RA-induced differentiation of P19 cells. A: Northern blot analysis of total RNA 
extracted from UD and RA-induced (day 3, day 6 and day 8) P19 cells. 40 u.g of total RNA obtained from different cell types (10 ug for 
mouse brain) was loaded in each line. Filter was hybridized to 32P-labeled chicken CaM cDNA probe. Autoradiograms were obtained after 2 h 
of exposure. B: Quantification of the changes in mRNA for the different isoforms of CaM during the course of RA-induced differentiation of 
P19 cells. Filter was scanned and analyzed using the Instant Imager System. 
leading to the hypothesis that A C isoforms could play a very 
important role during cell differentiation. 
In summary, the present study provides evidence for the 
importance of the C a 2 + / c A M P signaling pathway in neuro-
ectodermal differentiation. Embryonic carcinoma PI 9 cells 
represent the first cell line expressing a basal C a 2 + / C a M -
stimulated A C activity. After R A induction, the C a 2 + / C a M 
A C activity increases 10-fold and this increase is supported by 
a specific up-regulation of AC8 m R N A . R A induction also 
leads to specific down-regulation of AC3 and up-regulation of 
AC2 and AC5 m R N A . P19 teratocarcinoma cells provide a 
powerful model to investigate the role of A C in neuronal 
differentiation as well as in the elucidation of the specific 
regulation of AC2, AC3 , AC5 and AC8 synthesis. 
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